Clinical trial NCT00249756: Re-Entry MTC for Offenders With MICA Disorders
Official title: Re-Entry MTC for Offenders With MICA Disorders
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Mental Disorders
Substance-Related Disorders
Keywords: Criminal Justice
Lead sponsor: National Development and Research Institutes, Inc.
Sponsor class: OTHER
Collaborators: name: National Institute on Drug Abuse (NIDA)
First posted: 2005-11-07
Enrollment: 610
Sex: MALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The purpose of this study is to examine the transition of offenders with both mental illness and chemical abuse (MICA) disorders from prison to the community, where continued treatment is generally considered necessary to sustain gains made by prison treatment, and to achieve successful outcomes. The project will determine the effectiveness of a modified therapeutic community (Re-Entry MTC) approach as compared to the case management and parole supervision currently provided. The study will also assess the relative impact on treatment outcomes of the type of treatment received while in prison and of the progress achieved in re-entry treatment.

Detailed description: Offenders having both mental illness and chemical abuse (MICA) disorders are a population of interest, in part because their special needs place exceptional demands on criminal justice and treatment systems, as well as on individuals and families. This study examines the crucial point of transition from prison to the community, where continued treatment for offenders is generally considered necessary to sustain gains made by prison treatment efforts, and to achieve successful outcomes. The project has two specific aims; Aim 1 is to test the effectiveness of Re entry MTC treatment relative to a control condition, and Aim 2 is to assess the relative impact on treatment outcomes of the type of treatment received while in prison and of the progress achieved in re-entry treatment.

On their release from prison, male offenders with MICA disorders who elect to participate in this study (N = 332), will be placed in either the experimental condition, (E) Re-entry Modified Therapeutic Community (Re-entry MTC) or the control condition, (C) Parole Supervision and Case Management currently provided, using a randomized block assignment procedure. The research employs a prospective, longitudinal, repeated measures assessment with five data collection points: baseline (Time 1, or T1) corresponding to entry into the Community Corrections facility and at 3 (T2), 6 (T3), 12 (T4), and 18 (T5) months post-baseline. The major study hypothesis is that the E condition (compared to the C condition) will produce significantly greater improvement in the presenting problems of the study participants, as measured by substance use, mental health symptoms, and criminal activities.

This project will advance scientific knowledge through a controlled study of the effectiveness of the MTC model, with demonstrated success in community settings, as a re-entry strategy for offenders with MICA disorders, thereby expanding the range of treatment models available to such clients in the community. In addition, the study will examine the degree to which prior prison treatment moderates the effectiveness of the Re-entry MTC, or the extent to which positive outcomes are independent of the type of treatment received during the prior incarceration. This distinction will inform program planning by establishing the value of MTC treatment in prison plus MTC during re-entry versus MTC re-entry treatment alone. Finally, the study tests a specific hypothesis about the degree to which the effectiveness of Re-entry MTC treatment is mediated by client progress during reentry, which will increase our understanding of the relationship between progress in treatment and post-treatment outcomes for offenders with MICA disorders.

Eligibility criteria: Inclusion Criteria:

* Male offenders with serious mental illness and co-occurring chemical abuse (MICA) disorders, as the term is currently applied in the CDOC Chemical abuse consists of any substance use or dependence disorder\[s\] diagnosis. Serious mental disorder\[s\] diagnosis includes DSM IV categories for: Bipolar Mood Disorders; Major Depressive Disorder; Paranoid/Delusional Disorders; Schizophrenic Disorders; Schizoaffective Disorder; and Post Traumatic Stress Disorder.

Exclusion Criteria:

* The study has no exclusion criteria other than programmatic criteria that exclude offenders who constitute a threat to themselves or to others in the community, as determined by the Community Corrections Board at the time the offender is placed in a Community Corrections facility.

Primary outcomes:
measure: CTCR Baseline & Follow-Up Protocol (CTCR Protocol)
timeFrame: Baseline and at 3, 6, 12, and 18 months
measure: Colorado Department of Corrections Record Information System (CDOC-RIS)
timeFrame: At 6, 12, and 18 months
measure: Biological Specimens
timeFrame: At 12 and 18 months
measure: Diagnostic Interview Survey-IV (DIS-IV)
timeFrame: At baseline
measure: Beck Depression Inventory-II (BDI-II)
timeFrame: At baseline and 3, 6, 12, and 18 months
measure: Symptom Checklist 90-R (SCL90-R)
timeFrame: At baseline and 3, 6, 12, and 18 months
measure: Rosenberg Self-Esteem (R-SES)
timeFrame: At baseline and 3, 6, 12, and 18 months
measure: Measures of Social Network (adapted)
timeFrame: At baseline and 3, 6, 12, and 18 months
measure: Client Assessment Inventory (CAI) & Staff Assessment Summary (SAS)
timeFrame: At 3 and 6 months
measure: Therapeutic Community Scale of Essential Elements Questionnaire(SEEQ)
timeFrame: administered monthly over the first six months of the project and quarterly thereafter
measure: Treatment Services Review (TSR)
timeFrame: administered monthly over the first six months of the project and quarterly thereafter
measure: Program Monitoring Form (PMF)
timeFrame: administered monthly over the first six months of the project and quarterly thereafter
Secondary outcomes:
measure: Quality of Employment Survey (QES)
timeFrame: At baseline and 3, 6, 12, and 18 months
measure: The Quality of Life Interview (QLI) - short form
timeFrame: At baseline and 3, 6, 12, and 18 months
Other outcomes:
Locations:
city: Caqon City
country: United States
facility: Arrowhead Correctional Facility
state: Colorado
city: Pueblo
country: United States
facility: San Carlos Correctional Facility
state: Colorado
city: Sterling
country: United States
facility: Sterling Correctional Facility
state: Colorado
Study officials:
affiliation: National Development and Research Institutes, Inc.
name: Stanley Sacks, Ph.D.
role: PRINCIPAL_INVESTIGATOR
References:
citation: Sacks S, Chaple M, Sacks JY, McKendrick K, Cleland CM. Randomized trial of a reentry modified therapeutic community for offenders with co-occurring disorders: crime outcomes. J Subst Abuse Treat. 2012 Apr;42(3):247-59. doi: 10.1016/j.jsat.2011.07.011. Epub 2011 Sep 22.